Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT/leucovorin plus mitomycin C in oxaliplatin- and irinotecan-resistant metastatic colorectal cancer
2007-006151-40Phase 2Active
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- Nov 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, uracil, folinic acid, mitomycin c in colorectal cancer (CRC), sponsored by San Luigi Gonzaga Hospital. Started Nov 2007; status: active.
02
Drugs
tegafururacilfolinic acidmitomycin c
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2007-006151-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006151-40.